BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38145757)

  • 1. Broadly neutralizing antibodies to combat influenza virus infection.
    Sun X; Ma H; Wang X; Bao Z; Tang S; Yi C; Sun B
    Antiviral Res; 2024 Jan; 221():105785. PubMed ID: 38145757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadly neutralizing antibodies recognizing different antigenic epitopes act synergistically against the influenza B virus.
    Zhai L; Zhang L; Jiang Y; Li B; Yang M; Victorovich KV; Aleksandrovna KT; Li M; Wang Y; Huang D; Zeng Z; Ren Z; Cao H; Zhu L; Wu Q; Xiao W; Zhang B; Wan C; Wang F; Xia N; Zhao W; Chen Y; Shen C
    J Med Virol; 2023 Jan; 95(1):e28106. PubMed ID: 36039848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses.
    Moin SM; Boyington JC; Boyoglu-Barnum S; Gillespie RA; Cerutti G; Cheung CS; Cagigi A; Gallagher JR; Brand J; Prabhakaran M; Tsybovsky Y; Stephens T; Fisher BE; Creanga A; Ataca S; Rawi R; Corbett KS; Crank MC; Karlsson Hedestam GB; Gorman J; McDermott AB; Harris AK; Zhou T; Kwong PD; Shapiro L; Mascola JR; Graham BS; Kanekiyo M
    Immunity; 2022 Dec; 55(12):2405-2418.e7. PubMed ID: 36356572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
    Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection.
    Zeng D; Xin J; Yang K; Guo S; Wang Q; Gao Y; Chen H; Ge J; Lu Z; Zhang L; Chen J; Chen Y; Xia N
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Immune Response towards Generation of Universal Anti-HA-Stalk Antibodies after Immunization of Broiler Hens with Triple H5N1/NA-HA-M1 VLPs.
    Gromadzka B; Chraniuk M; Hovhannisyan L; Uranowska K; Szewczyk B; Narajczyk M; Panasiuk M
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes.
    Chiba S; Kong H; Neumann G; Kawaoka Y
    mBio; 2023 Aug; 14(4):e0062223. PubMed ID: 37466314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes.
    Guthmiller JJ; Han J; Li L; Freyn AW; Liu STH; Stovicek O; Stamper CT; Dugan HL; Tepora ME; Utset HA; Bitar DJ; Hamel NJ; Changrob S; Zheng NY; Huang M; Krammer F; Nachbagauer R; Palese P; Ward AB; Wilson PC
    Sci Transl Med; 2021 Jun; 13(596):. PubMed ID: 34078743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.
    Tan GS; Lee PS; Hoffman RM; Mazel-Sanchez B; Krammer F; Leon PE; Ward AB; Wilson IA; Palese P
    J Virol; 2014 Dec; 88(23):13580-92. PubMed ID: 25210195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of broad-spectrum neutralizing antibodies against influenza A virus and evaluation of their prophylactic efficacy in mice.
    Son S; Ahn SB; Kim G; Jang Y; Ko C; Kim M; Kim SJ
    Antiviral Res; 2023 May; 213():105591. PubMed ID: 37003306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad neutralizing antibody-based strategies to tackle influenza.
    Sun X; Ling Z; Yang Z; Sun B
    Curr Opin Virol; 2022 Apr; 53():101207. PubMed ID: 35131735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus.
    Huang J; Huang N; Fan M; Zhao L; Luo Y; Ding P; Tian M; Liu Q; Guo Y; Zhao J; Zheng Y; Zhang H; Ping J
    Virol J; 2020 Dec; 17(1):191. PubMed ID: 33287849
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Sutton TC; Lamirande EW; Bock KW; Moore IN; Koudstaal W; Rehman M; Weverling GJ; Goudsmit J; Subbarao K
    J Virol; 2017 Dec; 91(24):. PubMed ID: 29046448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans.
    Nachbagauer R; Wohlbold TJ; Hirsh A; Hai R; Sjursen H; Palese P; Cox RJ; Krammer F
    J Virol; 2014 Nov; 88(22):13260-8. PubMed ID: 25210189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines.
    Lim CML; Komarasamy TV; Adnan NAAB; Radhakrishnan AK; Balasubramaniam VRMT
    Influenza Other Respir Viruses; 2024 Mar; 18(3):e13276. PubMed ID: 38513364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.
    Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q
    J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.
    Zost SJ; Wu NC; Hensley SE; Wilson IA
    J Infect Dis; 2019 Apr; 219(Suppl_1):S38-S45. PubMed ID: 30535315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface.
    Zhu X; Han J; Sun W; Puente-Massaguer E; Yu W; Palese P; Krammer F; Ward AB; Wilson IA
    Proc Natl Acad Sci U S A; 2022 May; 119(21):e2200821119. PubMed ID: 35594401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.